212 related articles for article (PubMed ID: 35299)
1. Proceedings of the National Conference on Clinical Trials Methodology.
Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):629-766. PubMed ID: 35299
[No Abstract] [Full Text] [Related]
2. The validity of "identical matching placebos".
Blumenthal DS; Burke R; Shapiro AK
Arch Gen Psychiatry; 1974 Aug; 31(2):214-5. PubMed ID: 4605362
[No Abstract] [Full Text] [Related]
3. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
[TBL] [Abstract][Full Text] [Related]
4. Proceedings of the Second Annual Conference on the Status of Predictive Tools in Application to Safety Evaluation: Hazards from Toxic Chemicals.
J Environ Pathol Toxicol; 1978; 2(1):1-223. PubMed ID: 31408
[No Abstract] [Full Text] [Related]
5. [How to improve drug development and utilization in pediatrics].
Pons G; Lassale C; Eschwege E
Therapie; 1999; 54(4):423-32. PubMed ID: 10667109
[TBL] [Abstract][Full Text] [Related]
6. Biological sex analysis in clinical research.
Woosley RL; Anthony M; Peck CC
J Womens Health Gend Based Med; 2000 Nov; 9(9):933-4. PubMed ID: 11103088
[No Abstract] [Full Text] [Related]
7. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
[TBL] [Abstract][Full Text] [Related]
8. The FDA and IBS drug development.
Mangel AW
Am J Gastroenterol; 2009 Dec; 104(12):3106; author reply 3106. PubMed ID: 19956135
[No Abstract] [Full Text] [Related]
9. When and how to stop a clinical trial: invited remarks.
Stamler J
Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):651-4. PubMed ID: 373949
[No Abstract] [Full Text] [Related]
10. [Ethical principles in preclinical and clinical experimentation on new drugs, with special reference to biological products].
Pérez Miravete A
Salud Publica Mex; 1986; 28(4):443-56. PubMed ID: 3775534
[No Abstract] [Full Text] [Related]
11. Issues of study design and data analysis.
D'Agostino RB
Inflamm Bowel Dis; 1998 May; 4(2):109-111; discussion 111-3. PubMed ID: 9687216
[No Abstract] [Full Text] [Related]
12. The Cancer Therapy Evaluation Program of the National Cancer Institute.
Muggia FM; Carter SK; Macdonald JS
Semin Oncol; 1981 Dec; 8(4):394-402. PubMed ID: 7323811
[No Abstract] [Full Text] [Related]
13. Tonsillectomy--trials and tribulations. Report on the National Institutes of Health consensus conference on indications for tonsillectomy and adenoidectomy.
Carden TS
JAMA; 1978 Oct; 240(18):1961-2. PubMed ID: 29139
[No Abstract] [Full Text] [Related]
14. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia.
Talley NJ
Am J Gastroenterol; 2009 Jun; 104(6):1339-41. PubMed ID: 19491845
[No Abstract] [Full Text] [Related]
15. Drug efficacy--double-blind studies.
Basmajian JV; Adler P; Ord RL
J Rehabil; 1974; 40(5):26-30. PubMed ID: 4606453
[No Abstract] [Full Text] [Related]
16. A framework for the quality assurance of clinical data.
Williams OD
Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):700-2. PubMed ID: 373958
[No Abstract] [Full Text] [Related]
17. Scientific misconduct in investigational drug trials.
Shapiro MF; Charrow RP
N Engl J Med; 1985 Mar; 312(11):731-6. PubMed ID: 3974649
[No Abstract] [Full Text] [Related]
18. US health agencies at odds over trial deaths.
Macilwain C
Nature; 1994 Jun; 369(6480):433. PubMed ID: 8202125
[No Abstract] [Full Text] [Related]
19. Pediatric drug research--the road less traveled.
Holdsworth MT
Ann Pharmacother; 2003 Apr; 37(4):586-91. PubMed ID: 12659620
[No Abstract] [Full Text] [Related]
20. Regulatory issues for Data and Safety Monitoring Committees.
Fisher L; Klibaner M
Am Heart J; 2001 Apr; 141(4):536-41. PubMed ID: 11275916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
